Safety of blonanserin and paliperidone extended-release in patients with acute schizophrenia.
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2013
Price : $35 *
At a glance
- Drugs Blonanserin (Primary) ; Paliperidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Therapeutic Use
- 20 Oct 2013 New trial record
- 09 Oct 2013 Results presented at the 26th Annual Congress of the European College of Neuropsychopharmacology.